Aromatase gene polymorphisms have also been related to comorbidities such as osteoporosis, Alzheimer's disease, or cardiovascular diseases and several cancers [24]. This evidence concerns the gene CYP19A1 and early-onset autosomal dominant Alzheimer disease.